Tuesday, January 25, 2022 2:57:36 AM
I heard all his interviews of the last 7 months. We can believe on good clinical results for Reborn and Reduvo. But this is all.
Reduvo might get approval according his message in 1st quarter but January is the most optimistic case.
Reborn results: nobody knows. Hopefully in 2022.
I am long and patient but my investment timing would have been totally different if he would have said in June 21 the truth. He is just another not trustworthy OTC CEO. I should have known better. My mistake not checking the history of his promises before investing.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM